TMPRSS2 and COVID-19: In an in vitro experiment with blood samples from patients with COVID-19, platelet expression of ACE2 receptor and TMPRSS2 was associated with platelet activation, platelet aggregation, PAC-1 binding, P-selectin expression, and clot retraction [101].